We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


GATC Acquires SOLiD™ DNA Sequencer from Applied Biosystems

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "GATC Acquires SOLiD™ DNA Sequencer from Applied Biosystems"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

GATC Biotech has announced the acquisition of a SOLiD™ DNA sequencing system from Applied Biosystems.

The system will be the third next generation sequencing technology to be installed in GATC's German research facility in Constance, which currently holds the GS FLX™ from Roche Diagnostics as well as the Genome Analyzer™ from Illumina.

According to GATC, being a part of Applied Biosystems' Early-Access Program, the SOLiD™ System is expected to be installed in early autumn this year and will boost the company's current sequencing capacity from 130 gigabases to 250 gigabases a year.

Therefore GATC will be the first and only commercial sequencing service provider worldwide being able to offer ultra high-throughput DNA analysis using all three leading next generation sequencing technologies, the company says. The total investment exceeds 2 million Euros.